Royal Bank of Canada »

Kiniksa Pharmaceuticals Intl P Ord Shs Cl A shares owned by Royal Bank of Canada

Quarter-by-quarter ownership of Kiniksa Pharmaceuticals Intl P Ord Shs Cl A (KNSA) shares owned by Royal Bank of Canada from 13F filings

Historical chart of Royal Bank of Canada investment in Kiniksa Pharmaceuticals Intl P Ord Shs Cl A

Tip: Access up to 7 years of quarterly data

All positions including Kiniksa Pharmaceuticals Intl P Ord Shs Cl A held by Royal Bank of Canada consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kiniksa Pharmaceuticals Intl P Ord Shs Cl A by Royal Bank of Canada

Quarter filed Position value Share count Share price at filing
2025-09-30 $14k 461 31.25
2025-06-30 $9.7M 223k 43.48
2025-03-31 $55k 2.5k 22.39
2024-12-31 $38k 1.9k 19.91
2024-09-30 $126k 5.2k 24.28
2024-06-30 $87k 4.6k 18.90

More positions owned by Royal Bank of Canada

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
Amazon (AMZN)
Toronto Dominion Bk Ont Com New (TD)
Rbc Cad (RY)
Bank Of Montreal Cadcom (BMO)
Bk Nova Cad (BNS)
Alphabet Cap Stk Cl A (GOOGL)
Invesco Qqq Tr Unit Ser 1 (QQQ)
JPMorgan Chase & Co. (JPM)
Broadcom (AVGO)
Ishares Tr Russell 2000 Etf (IWM)

View all positions for Royal Bank of Canada

Top funds holding Kiniksa Pharmaceuticals Intl P Ord Shs Cl A

Rubric Capital Management
Vanguard Group
Baker Bros. Advisors
Tang Capital Management
Fairmount Funds Management
Acadian Asset Management
D. E. Shaw & Co
Arrowstreet Capital, Limited Partnership
Morgan Stanley
Millennium Management
Pictet Asset Management Holding SA
FMR
Connor, Clark & Lunn Investment Management
Qube Research & Technologies
Parkman Healthcare Partners

View all funds holding Kiniksa Pharmaceuticals Intl P Ord Shs Cl A